Hunan Hansen Pharmaceutical Co. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -11.68% vs 28.50% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -66.78% vs 725.71% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "263.20",
          "val2": "298.00",
          "chgp": "-11.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.40",
          "val2": "72.40",
          "chgp": "-20.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "0.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "38.40",
          "val2": "115.60",
          "chgp": "-66.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "217.90%",
          "val2": "207.20%",
          "chgp": "1.07%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.44% vs 5.17% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -10.04% vs 7.41% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,026.80",
          "val2": "992.70",
          "chgp": "3.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "270.00",
          "val2": "278.00",
          "chgp": "-2.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "2.90",
          "chgp": "-31.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.80",
          "val2": "2.10",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "198.10",
          "val2": "220.20",
          "chgp": "-10.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "222.50%",
          "val2": "238.30%",
          "chgp": "-1.58%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

263.20

298.00

-11.68%

Operating Profit (PBDIT) excl Other Income

57.40

72.40

-20.72%

Interest

0.30

0.30

Exceptional Items

0.60

0.50

20.00%

Consolidate Net Profit

38.40

115.60

-66.78%

Operating Profit Margin (Excl OI)

217.90%

207.20%

1.07%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -11.68% vs 28.50% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -66.78% vs 725.71% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,026.80

992.70

3.44%

Operating Profit (PBDIT) excl Other Income

270.00

278.00

-2.88%

Interest

2.00

2.90

-31.03%

Exceptional Items

1.80

2.10

-14.29%

Consolidate Net Profit

198.10

220.20

-10.04%

Operating Profit Margin (Excl OI)

222.50%

238.30%

-1.58%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 3.44% vs 5.17% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -10.04% vs 7.41% in Dec 2024

All Annual Results